American Gene Technologies™ International (AGT) is a leader in the development of advanced genetic technologies to cure major human diseases such as cancer, metabolic disorders and infectious diseases. AGT is demonstrating the viability of a new wave of medicine with the promise of improving and extending human life and ending the suffering caused by formerly incurable diseases. In collaboration with globally recognized scientists with decades of disease research at leading institutions and partnerships with leading manufacturers in the cell and gene therapy arena, AGT is accelerating the delivery of treatments to global patient populations.
Thousands of lentiviral vectors have been developed, tested and banked to make the drug development process more efficient.
World-class researchers partner with American Gene Technologies to design drugs using gene therapies within our lentiviral vectors.
Our lentiviral vectors represent the latest advance in pharmaceuticals, and can be used to target a wide variety of diseases and conditions.
Internationally recognized scientists supporting roadmaps to drug development to combat multiple diseases and conditions.
Send this to a friend
